6-76018812-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PM5PP3_ModeratePP5
The NM_001563.4(IMPG1):c.713T>C(p.Leu238Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L238R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001563.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IMPG1 | NM_001563.4 | c.713T>C | p.Leu238Pro | missense_variant | 7/17 | ENST00000369950.8 | NP_001554.2 | |
IMPG1 | NM_001282368.2 | c.479T>C | p.Leu160Pro | missense_variant | 6/16 | NP_001269297.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IMPG1 | ENST00000369950.8 | c.713T>C | p.Leu238Pro | missense_variant | 7/17 | 1 | NM_001563.4 | ENSP00000358966 | P2 | |
IMPG1 | ENST00000611179.4 | c.479T>C | p.Leu160Pro | missense_variant | 6/16 | 5 | ENSP00000481913 | A2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Retinal dystrophy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 31, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 08, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant disrupts the p.Leu238 amino acid residue in IMPG1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23993198). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 865770). This missense change has been observed in individuals with clinical features of vitelliform macular dystrophy (PMID: 28644393; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 238 of the IMPG1 protein (p.Leu238Pro). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at